184 related articles for article (PubMed ID: 19605807)
1. Prasugrel in clinical practice.
Bhatt DL
N Engl J Med; 2009 Sep; 361(10):940-2. PubMed ID: 19605807
[No Abstract] [Full Text] [Related]
2. Weighing benefits and risks--the FDA's review of prasugrel.
Unger EF
N Engl J Med; 2009 Sep; 361(10):942-5. PubMed ID: 19726770
[No Abstract] [Full Text] [Related]
3. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
4. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
5. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
7. Prasugrel: Clinical development and therapeutic application.
Guerra DR; Tcheng JE
Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
[TBL] [Abstract][Full Text] [Related]
8. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
9. Thienopyridine antiplatelet agents: focus on prasugrel.
Freeman MK
Consult Pharm; 2010 Apr; 25(4):241-57. PubMed ID: 20511177
[TBL] [Abstract][Full Text] [Related]
10. Bleeding risks with prasugrel in the TRITON trial: good news ... bad news.
Serebruany VL
Cardiology; 2008; 111(4):265-7. PubMed ID: 18434736
[No Abstract] [Full Text] [Related]
11. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
[No Abstract] [Full Text] [Related]
12. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
13. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
[TBL] [Abstract][Full Text] [Related]
14. Prasugrel development - claims and achievements.
Serebruany V; Shalito I; Kopyleva O
Thromb Haemost; 2009 Jan; 101(1):14-22. PubMed ID: 19132184
[TBL] [Abstract][Full Text] [Related]
15. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
16. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
Thomas D; Giugliano RP
Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
[TBL] [Abstract][Full Text] [Related]
17. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
Lazar LD; Lincoff AM
Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295
[TBL] [Abstract][Full Text] [Related]
18. Future of oral antiplatelet therapy: four challenged hypotheses.
Serebruany VL; Makarov LM
Thromb Haemost; 2009 Jun; 101(6):1041-3. PubMed ID: 19492145
[No Abstract] [Full Text] [Related]
19. Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.
Motovska Z; Widimsky P
Vasc Health Risk Manag; 2009; 5(1):475-81. PubMed ID: 19475783
[TBL] [Abstract][Full Text] [Related]
20. Prasugrel, a new platelet inhibitor.
Yee D; Meyer J; Caliendo G; Oviedo V
Mt Sinai J Med; 2010; 77(3):315-23. PubMed ID: 20506458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
